EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Clinical outcomes of cyclophosphamide therapy in relentless placoid choroiditis: A descriptive case series

Miguel Pedroza-Seres, Carlos E Rodríguez-López

Indian Journal of Ophthalmology · 2025

DOI: 10.4103/ijo.ijo_348_25 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Indian Journal of Ophthalmology, 2025. Verfasst von Miguel Pedroza-Seres und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Uveitis and Ocular Immunology, Instituto de Oftalmología FAP Conde de Valenciana, Mexico City, Mexico. Hauptthemen laut MEDLINE: Choroid, Choroiditis, Cyclophosphamide, Visual Acuity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To describe the clinical presentation and visual outcomes of relentless placoid choroiditis (RPC) in four patients treated with intravenous cyclophosphamide, a treatment not extensively studied in this condition.

Background

RPC is a rare and recently described ocular disease characterized by a prolonged and progressive clinical course, widespread lesions, and unknown etiology. There is no consensus on its treatment, and the use of cyclophosphamide in RPC has not been extensively studied. Case Presentation: Four RPC patients treated with intravenous cyclophosphamide showed significant visual improvement (mean best-corrected visual acuity [BCVA] improved from 20/125 to 20/32) with minimal side effects.

Conclusion

This case series demonstrates favorable outcomes with intravenous cyclophosphamide in RPC, supporting its potential as a safe, effective, and cost-efficient treatment option.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChoroidChoroiditisCyclophosphamideVisual AcuityHumansFluorescein AngiographyFollow-Up StudiesFundus OculiImmunosuppressive AgentsTomography, Optical CoherenceTreatment Outcome

Stichwörter der Autor:innen

Choroid diseaseschoroiditiscyclophosphamideposterior uveitisrelentless placoid chorioretinitiswhite dot syndromes

Substanzen

CyclophosphamideImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Uveitis and Ocular Immunology, Instituto de Oftalmología FAP Conde de Valenciana, Mexico City, Mexico.
  • Department of Retina and Vitreous, Instituto de Oftalmología FAP Conde de Valenciana, Mexico City, Mexico.

Zitieren

APA

Pedroza-Seres, M., & Rodríguez-López, C. E. (2025). Clinical outcomes of cyclophosphamide therapy in relentless placoid choroiditis: A descriptive case series. Indian Journal of Ophthalmology. https://doi.org/10.4103/ijo.ijo_348_25

Vancouver

Pedroza-Seres M, Rodríguez-López CE. Clinical outcomes of cyclophosphamide therapy in relentless placoid choroiditis: A descriptive case series. Indian Journal of Ophthalmology. 2025. doi:10.4103/ijo.ijo_348_25

BibTeX
@article{PedrozaSeres2025,
  author = {Pedroza-Seres, Miguel and Rodríguez-López, Carlos E},
  title = {Clinical outcomes of cyclophosphamide therapy in relentless placoid choroiditis: A descriptive case series},
  journal = {Indian Journal of Ophthalmology},
  year = {2025},
  doi = {10.4103/ijo.ijo_348_25}
}
Kostenlos starten →